Cloverfields Capital Group, LP Astrazeneca PLC Transaction History
Cloverfields Capital Group, LP
- $271 Million
- Q1 2025
A detailed history of Cloverfields Capital Group, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 35,614 shares of AZN stock, worth $2.49 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
35,614
Previous 35,733
0.33%
Holding current value
$2.49 Million
Previous $2.34 Million
11.79%
% of portfolio
0.96%
Previous 0.85%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.99 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.84 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.49 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.23 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.19 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $217B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...